The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B

Neurosurgery

Volumn 40, Issue 2, 1997, Pages 271-275

  Kaba, Samer E ^a   DeMonte, Franco ^a   Bruner, Janet M ^a   Kyritsis, Athanassios P ^a   Jaeckle, Kurt A ^a   Levin, Victor ^a   Yung, W K Alfred ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Biological modifiers; Brain neoplasms; Interferon; Meningioma

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER INHIBITION; CANCER REGRESSION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MENINGIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR VOLUME;

ADULT; AGED; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 0031030863     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199702000-00007     Document Type: Article

References (27)

1. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM: Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 20:525-528, 1987.
2. Bergström M, Muhr C, Lundberg PO, Gati I, Gudjonsson O, Lilja A, Spännare B, Långström B: Modulation of tumor metabolism using hormonally acting drugs in patients with meningioma. J Endocrinol Invest 12[Suppl 2]:91, 1989 (abstr).
3. Creagan ET, Ahmann DL, Frytak S, Long HJ, Itri LM: Recombinant leukocyte A interferon (rIFN-alpha A) in the treatment of disseminated malignant melanoma: Analysis of complete and long-term responding patients. Cancer 58:2576-2578, 1986.
4. De la Monte SM, Flickinger J, Lingwood RM: Histopathologic features predicting recurrence of meningiomas following subtotal resection. Am J Surg Pathol 10:836-843, 1986.
5. DeMonte F: Current management of meningiomas. Oncology 9:83-96, 1995.
6. Engenhart R, Kimming BN, Hover KH, Wowra B, Sturm V: Stereotactic single dose radiation therapy of benign intracranial meningiomas. Int J Radiat Oncol Biol Phys 19:1021-1026, 1990.
7. Ezekowitz RA, Mullinken JB, Folkman J: Interferon alpha-2a therapy for life threatening hemangiomas of infancy. N Engl J Med 326:1456-1463, 1992.
8. Folkman J, Ingber D: Inhibition of angiogenesis. Semin Cancer Biol 3:89-96, 1992.
9. Goldsmith BJ, Wara WM, Wilson CB, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80:195-201, 1994.
10. Golomb HM, Jacobs A, Fefer A, Ozer H, Thompson J: Alpha-2 interferon therapy of hairy-cell leukemia: A multicenter study of 64 patients. J Clin Oncol 4:900-905, 1986.
11. Grunberg SM, Weiss MH, Spitz IM, Ahmadi J, Sadun A, Russell CA, Lucci L, Stevenson LL: Treatment of unresectable meningiomas with the antiprogesteronal agent mifepristone. J Neurosurg 74:861-866, 1991.
12. Jääskeläinen J, Haltia M, Servo A: Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233-242, 1985.
13. Jääskeläinen J, Laasonen E, Kärkkäinen J, Haltia M, Troupp H: Hormone treatment of meningiomas: Lack of response to medroxyprogesterone acetate (MPA) - A pilot study of five cases. Acta Neurochir (Wien) 80:35-41, 1986.
14. Koper J, Zwarthoff E, Hagemeijer A, Braakman R, Avezaat CJ, Bergstrom M, Lamberts SW: Inhibition of the growth of cultured human meningioma cells by recombinant interferon-a. Eur J Cancer 27:416-419, 1991.
15. Kyritsis AP: Chemotherapy for meningiomas. J Neurooncol 29: 269-272, 1996.
16. Levin VA, Leibel S, Gutin PH: Neoplasms of the central nervous system, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology. Philadelphia, J.B. Lippincott, ed 5 (in press).
17. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann R, Martuza R: Meningioma: Analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62:18-24, 1985.
18. Neidhart JA: Interferon therapy for the treatment of renal cancer. Cancer 57[Suppl 8]:1696-1699, 1986.
19. Niederle N, Moritz T, Kloke O, Wandl U, May D, Becher R, Franz T, Opalka B, Schmidt CG: Interferon alpha-2B in acute- and chronic-phase chronic myelogenous leukaemia: Initial response and long-term results in 54 patients. Eur J Cancer 27[Suppl 4]:S7-S14, 1991.
20. Philipon J, Cornu P: The recurrence of meningiomas, in Al-Mefty O (ed): Meningiomas. New York, Raven Press, 1991, pp 87-105.
21. Rachlin JR, Rosenblum ML: Etiology and biology of meningiomas, in Al-Mefty O (ed): Meningiomas. New York, Raven Press, 1991, pp 22-37.
22. Ricketts RR, Hatley RM, Corden BJ, Sabio H, Howell CG: Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 219:605-612, 1994.
23. Simpson D: Recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22-39, 1957.
24. Taylor BW Jr, Marcus RB Jr, Freidman WA, Ballinger WE Jr, Million RR: The meningioma controversy: Postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15:299-304, 1988.
25. Wober-Bingol C, Wober C, Marosi C, Prayer D: Interferon alpha-2B for meningioma. Lancet 345:331, 1995 (letter).
26. Younis GA, Sawaya R, DeMonte F, Hess K, Albrecht S, Bruner J: Aggressive meningeal tumors: Review of a series. J Neurosurg 82:17-27, 1995.
27. Neurosurgery, Vol. 40, No. 2, February 1997